MLTX - CIK 0001821586
MoonLake Immunotherapeutics has filed 296 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Major company event | 8-K | 2025-06-06 | 2025-06-05 |
| SCHEDULE 13G/A | - | 2025-05-14 | - |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| Major company event | 8-K | 2025-04-29 | 2025-04-29 |
| Annual report to shareholders | ARS | 2025-04-22 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-22 | - |
| Proxy statement | DEF 14A | 2025-04-22 | 2025-06-05 |
| Major company event | 8-K | 2025-04-03 | 2025-03-31 |
| Insider trade | 4 | 2025-03-03 | 2025-02-27 |
| Insider trade | 4 | 2025-03-03 | 2025-02-27 |
| Insider trade | 4 | 2025-03-03 | 2025-02-27 |
| Annual report | 10-K | 2025-02-26 | 2024-12-31 |
| Major company event | 8-K | 2025-02-26 | 2025-02-26 |
| SCHEDULE 13G | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| Insider trade | 4 | 2025-01-22 | 2025-01-20 |
| Major company event | 8-K | 2024-12-18 | 2024-12-12 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Major company event | 8-K | 2024-11-07 | 2024-11-07 |
| Insider trade | 4 | 2024-10-08 | 2024-10-04 |
| Insider trade | 4 | 2024-10-08 | 2024-10-04 |
| Activist ownership stake (update) | SC 13D/A | 2024-10-08 | - |
| Major company event | 8-K | 2024-09-11 | 2024-09-11 |
| Quarterly report | 10-Q | 2024-08-07 | 2024-06-30 |
| Major company event | 8-K | 2024-08-07 | 2024-08-07 |
| Major company event | 8-K | 2024-06-10 | 2024-06-10 |
| Insider trade | 4 | 2024-06-10 | 2024-06-06 |
| Insider trade | 4 | 2024-06-07 | 2024-06-06 |
| Insider trade | 4 | 2024-06-07 | 2024-06-06 |
| Insider trade | 4 | 2024-06-07 | 2024-06-06 |
| Insider trade | 4 | 2024-06-07 | 2024-06-06 |
| Insider trade | 4 | 2024-06-07 | 2024-06-06 |
| Major company event | 8-K | 2024-06-06 | 2024-06-05 |
| SEC correspondence | UPLOAD | 2024-05-13 | - |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |
| Major company event | 8-K | 2024-05-07 | 2024-05-07 |
| Annual report (amended) | 10-K/A | 2024-05-07 | 2023-12-31 |
| Company correspondence | CORRESP | 2024-05-07 | - |
| SEC correspondence | UPLOAD | 2024-04-29 | - |
| Annual report to shareholders | ARS | 2024-04-24 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-24 | - |
| Proxy statement | DEF 14A | 2024-04-24 | 2024-06-05 |
| Major company event | 8-K | 2024-03-11 | 2024-03-10 |
| Activist ownership stake (update) | SC 13D/A | 2024-03-05 | - |